Literature DB >> 12473072

Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype.

Alicia Rivera1, Israel Alberti, Ana B Martín, José A Narváez, Adelaida de la Calle, Rosario Moratalla.   

Abstract

Dopamine is one of the principal neurotransmitters in the basal ganglia, where it plays a critical role in motor control and cognitive function through its interactions with the specific dopamine receptors D1 to D5. Although the activities mediated by most dopamine receptor subtypes have already been determined, the role of the D5 receptor subtype in the basal ganglia has still not been established. Furthermore, it is often difficult to distinguish between dopamine D5 and D1 receptors as they are stimulated by the same ligands, and they have a similar molecular structure and pharmacology. In an effort to understand the differences between these two receptor subtypes, we have studied the distribution of neurons containing D5 receptors in the striatum, and their molecular phenotype. As a result, we show that the D5 receptor subtype is present in two different populations of striatal neurons, projection neurons and interneurons. Overall, the abundance of this receptor subtype in the striatum is low, particularly in striatal projection neurons of both the direct and indirect projection pathways. In contrast, the expression of D5 receptors in striatal interneurons (cholinergic, somatostatin- or parvalbumin-positive neurons) is high, while low to moderate expression was observed in calretinin-positive neurons. Our results demonstrate the presence of D5 receptors in all the striatal cell populations so far described, although at different intensities in each. The fact that a large number of striatal neurons express the D5 receptor subtype suggests that this receptor fulfils an important function in the process of integrating information in the striatum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473072     DOI: 10.1046/j.1460-9568.2002.02280.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  38 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.

Authors:  Morgane Thomsen; Simon Barak Caine
Journal:  Eur J Pharmacol       Date:  2016-02-11       Impact factor: 4.432

Review 3.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.

Authors:  Stephen Sammut; Kristina E Bray; Anthony R West
Journal:  Psychopharmacology (Berl)       Date:  2007-01-06       Impact factor: 4.530

5.  Dopaminergic and cholinergic modulation of striatal tyrosine hydroxylase interneurons.

Authors:  Osvaldo Ibáñez-Sandoval; Harry S Xenias; James M Tepper; Tibor Koós
Journal:  Neuropharmacology       Date:  2015-04-20       Impact factor: 5.250

6.  Opposite effects of stimulant and antipsychotic drugs on striatal fast-spiking interneurons.

Authors:  Alexander B Wiltschko; Jeffrey R Pettibone; Joshua D Berke
Journal:  Neuropsychopharmacology       Date:  2010-01-20       Impact factor: 7.853

Review 7.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

8.  Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling.

Authors:  Nao Chuhma; Susana Mingote; Holly Moore; Stephen Rayport
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

9.  Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance.

Authors:  Ramalingam Vetrivelan; Mei-Hong Qiu; Celene Chang; Jun Lu
Journal:  Front Neuroanat       Date:  2010-11-23       Impact factor: 3.856

10.  D5 dopamine receptors are required for dopaminergic activation of phospholipase C.

Authors:  Asha Sahu; Kimberly R Tyeryar; Habiba O Vongtau; David R Sibley; Ashiwel S Undieh
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.